Minghui Li
- Cancer Research top 5%
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 5
- Molecular Biology top 10%
- Circular RNAs in diseases 5
- Mitochondrial Function and Pathology 3
- Congenital heart defects research 3
- Extracellular vesicles in disease 3
-
- Cardiac electrophysiology and arrhythmias 3
- Pharmacology top 10%
- Pharmacology top 10%
-
- Cancer Cells and Metastasis 6
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Minghui Li
41 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 446
- Molecular Biology 816
- Cardiology and Cardiovascular Medicine 198
- Pharmacology 102
- Pharmacology 51
Countries citing papers authored by Minghui Li
This map shows the geographic impact of Minghui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghui Li more than expected).
Fields of papers citing papers by Minghui Li
This network shows the impact of papers produced by Minghui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghui Li. The network helps show where Minghui Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Minghui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 25 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 23 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 49 | |
| 12 | 2020 | 32 | |
| 13 | 2019 | 21 | |
| 14 | 2018 | 108 | |
| 15 | 2017 | 5 | |
| 16 | 2015 | 40 | |
| 17 | 2014 | 108 | |
| 18 | 2014 | 13 | |
| 19 | 2013 | 63 | |
| 20 | 2012 | 44 |
About Minghui Li
Minghui Li is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 43 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer Cells and Metastasis (6 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (5 papers), Mitochondrial Function and Pathology (3 papers), Congenital heart defects research (3 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Cancer Research (446 citations), Molecular Biology (816 citations) and Cardiology and Cardiovascular Medicine (198 citations). Minghui Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Tiansong Xia, Shui Wang, Wei Zhu, Xin Zhou, Yao‐Jun Zhang, Javaid Iqbal, Zebo Huang, Shao‐Liang Chen, Zhimei Wang and Shaohua Yang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.